Last update 21 Nov 2024
JRF-103
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Mechanism EGFR T790M inhibitors(EGFR T790M inhibitors), EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), EGFR exon 21 L858R mutation inhibitors + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization  Jinrui FoundationStartup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with JRF-103评价JRF103片在晚期实体瘤患者中的安全性和有效性的开放、平行、多中心、II期临床研究
[Translation] An open, parallel, multicenter, phase II clinical study to evaluate the safety and efficacy of JRF103 tablets in patients with advanced solid tumors
评价JRF103片在晚期实体瘤患者中的安全性、耐受性、药代动力学特征及初步有效性的开放、多中心、I/II期临床研究
[Translation] An open, multicenter, phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of JRF103 tablets in patients with advanced solid tumors
An open, multi-center, phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary effectiveness of JRF103 tablets in patients with advanced solid tumors
100 Clinical Results associated with JRF-103
Login to view more data
100 Translational Medicine associated with JRF-103
Login to view more data
100 Patents (Medical) associated with JRF-103
Login to view more data
1
Literatures (Medical) associated with JRF-10301 Sep 2022Bioanalysis
An ultra-performance LC–MS/MS method for determination of JRF103 in human plasma: application in first in-patient study
Article
Author: Wang, Zhenlei ; Liu, Runhan ; Wang, Yongsheng ; Qi, Xiaohui ; Qiu, Neng ; Wang, Xiaoxu ; Jin, Ying ; Li, Fangqun ; Zhang, Mengyu ; Fu, Lisha ; Di, Xiangjie
100 Deals associated with JRF-103
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | CN | Jinrui FoundationStartup | 24 May 2024 |
| Solid tumor | IND Application | US | 30 Jan 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free